L. E. Bermudez, Petrofsky, M., and Goodman, J.,
“Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”,
Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.
L. E. Bermudez, Young, L. S., and Inderlied, C. B.,
“Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
M. Shortencar Tartis, McCallan, J., Lum, A. F. H., LaBell, R., Stieger-Vanegas, S. M., Matsunaga, T. O., and Ferrara, K. W.,
“Therapeutic effects of paclitaxel-containing ultrasound contrast agents.”,
Ultrasound in medicine & biology, vol. 32, no. 11, pp. 1771-80, 2006.
B. P. Dolan, Gibbs, K. D., and Ostrand-Rosenberg, S.,
“Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 176, no. 3, pp. 1447-55, 2006.